Skip to main content

Table 1 Demographics and clinical characteristics for DS, NDS and HC groups

From: Eye movement characteristics in male patients with deficit and non-deficit schizophrenia and their relationships with psychiatric symptoms and cognitive function

 

DS (n = 37)

NDS (n = 49)

HC (n = 80)

F/Z/χ2/t

P

Age (years)

50.00 ± 10.509△

45.86 ± 10.809#

40.48 ± 11.842

9.819

< 0.001

Education (years)

9.65 ± 2.251△

10.35 ± 3.244#

13.78 ± 3.590

28.024

< 0.001

Age at onset (years)

23.7365 ± 6.76

26.61 ± 9.808

 

− 1.612

0.111

Duration of disease (years)

26.27 ± 9.137**

19.04 ± 8.541

 

3.771

< 0.001

CPZ-equivalent daily dose (mg/day)

375 (280)

360 (210)

 

-0.725

0.468

Marital status [example (%)

   

60.169

< 0.001

 Unmarried

30 (33.7)

41 (46.1)

18 (20.2)

  

 Married

7 (9.1)

8 (10.4)

62 (80.5)

  

Family history [example (%)]

   

40.653

< 0.001

 Positive

17 (51.5)

16 (48.5)

0 (0.0)

  

 Negative

20 (15.0)

33 (24.8)

80 (60.2)

  

Use rate of anticholinergic drugs [example (%)

17 (54.8)

14 (45.2)

 

2.761

0.097

Smoking ratio (%)

13 (18.6)

26 (37.1)

31 (44.3)

3.518

0.172

SDS total score

13.62 ± 1.846**

8.86 ± 2.111

 

10.927

< 0.001

SAPS total score

9.22 ± 2.083

9.67 ± 0.944

 

− 1.364

0.176

Hallucinations

1.57 ± 0.603

1.57 ± 0.500

 

− 0.259

0.796

Delusions

2.08 ± 0.894

2.29 ± 0.540

 

− 1.317

0.191

Bizarre behavior

3.05 ± 0.911

2.98 ± 0.989

 

0.357

0.722

Positive thought disorder

2.54 ± 0.869

2.84 ± 0.624

 

− 1.840

0.069

SANS total score

44.81 ± 5.929**

31.27 ± 4.729

 

11.786

< 0.001

Affective flattening

11.30 ± 1.525**

9.12 ± 1.889

 

5.904

< 0.001

Alogia

10.76 ± 2.006**

6.90 ± 1.403

 

10.000

< 0.001

Avolition

8.65 ± 1.495**

5.53 ± 1.101

 

10.687

< 0.001

Anhedonia

9.81 ± 2.526**

6.24 ± 1.164

 

7.972

< 0.001

Inattention

4.41 ± 0.927**

3.47 ± 0.68

 

5.180

< 0.001

  1. Mean ± SD; Median (quartile spacing); DS: defificit schizophrenia; NDS: non-defificit schizophrenia; HC: healthy controls; SANS: the Scale for the Assessment of Negative Symptoms; SAPS: the Scale for the Assessment of Positive Symptoms; SDS: schedule for the defificit syndrome; CPZ: chlorpromazine
  2. **P < 0.001 DS vs. NDS;
  3. *P < 0.05 DS vs. NDS;
  4. △P < 0.05 DS vs. HC;
  5. #P < 0.05 NDS vs. HC